Chargement en cours...
2219: Amyotrophic lateral sclerosis, stem cells and TALENted technology
OBJECTIVES/SPECIFIC AIMS: The current treatment for amyotrophic lateral sclerosis (ALS) includes systemic delivery of neurotrophic factors (NTFs). Although this approach may seem theoretically sound, NTF efficacy within the central nervous system (CNS) is largely limited by the blood-brain barrier....
Enregistré dans:
| Publié dans: | J Clin Transl Sci |
|---|---|
| Auteurs principaux: | , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Cambridge University Press
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6798916/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1017/cts.2017.212 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|